Clinical Trials Browser

Endometrial Neoplasms

NCT01857934 2025-11-17

Therapy for Children With Advanced Stage Neuroblastoma

Phase 2 Active not recruiting

153 enrolled 12 charts

CNS

Neuroblastoma

NCT06550141 2025-11-14

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Phase 2 Recruiting

28 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03942224 2024-06-21

DeRIVE

Phase 2 Active not recruiting

49 enrolled

Plasma cell

Multiple Myeloma

NCT06115174 2023-11-02

CRC - PTX

Phase 4 Unknown

44 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05073250 2023-05-12

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

Phase 2 Unknown

40 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT03112590 2023-04-19

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Phase 1/2 Completed

51 enrolled 13 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02713373 2022-10-06

Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery

Phase 1/2 Completed

45 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT04315467 2022-06-16

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Phase 1 Completed

10 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02855086 2020-03-31

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

Phase 1/2 Terminated

3 enrolled 7 charts

CNS

Brain Neoplasms, Glioma

NCT00681993 2019-01-22

PBIC

Phase NA Completed

35 enrolled

Breast

Breast Neoplasms

NCT03631836 2018-08-17

MARELLE01

Phase 1 Unknown

34 enrolled

CNS

Glioblastoma

NCT00989586 2017-02-06

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Phase 1/2 Completed

35 enrolled 11 charts

Lymphoid

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00052403 2014-01-16

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00142155 2011-06-27

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Phase NA Completed

300 enrolled

Lymphoid

Waldenstrom Macroglobulinemia

Clinical Trials

ALPINE: Maintenance Letrozole/Abemaciclib

Therapy for Children With Advanced Stage Neuroblastoma

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

DeRIVE

CRC - PTX

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

PBIC

MARELLE01

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia